AHA: Sotagliflozin Beneficial for T2DM With Heart Failure
Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.